-
Treatment Patterns Post-CAR T Cell Therapy in Patients With Hematologic Malignancies: A Real-World US Study
Mar 10, 2025, 14:00 PM -
Overall Survival in People Living with HIV, Who Experienced Progressive Multifocal Leukoencephalopathy
Mar 10, 2025, 14:00 PM -
Budget Impact Analysis of Lanadelumab Versus C1 Inhibitor for Hereditary Angioedema Long Term Prophylaxis: A Brazilian Private Sector Perspective
Mar 10, 2025, 14:00 PM -
Advancing Health Equity in Economic Evaluations, With The Distributional Generalized Risk-Adjusted Cost-Effectiveness (DGRACE) Model
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Axicabtagene Ciloleucel as a Second-Line Treatment for Diffuse Large B-Cell Lymphoma in China
Mar 10, 2025, 14:00 PM -
Evidence for the Cumulative Impact of Social Determinants of Health (SDOH) on Cancer Mortality: A Scoping Review
Mar 10, 2025, 14:00 PM -
Analysis of Real-World Evidence Use Across FDA Submissions in 2022 and 2023
Mar 10, 2025, 14:00 PM -
Exploring Contemporary Variability in PDMP Budgets and Data Sharing Across the United States
Mar 10, 2025, 14:00 PM -
Mapping the ADDQoL to the EQ-5D-5L and SF-6Dv2 among Chinese Patients with Type 2 Diabetes Mellitus
Mar 10, 2025, 14:00 PM -
China's National Reimbursement Drug List (NRDL) Negotiation: Value Considerations and Key Factors Influencing Payment Standards
Mar 10, 2025, 14:00 PM -
The Use of QALYs in Decision-Making in Europe, Canada, and the US: A Qualitative Review of Methodological Guidance
Mar 10, 2025, 14:00 PM -
Obesity Impact on Incidence of Chronic Comorbid Conditions
Mar 10, 2025, 14:00 PM -
Evaluating PICOs Requested by Member States During Scoping for EU HTA Versus Those Covered in Actual HTAs
Mar 10, 2025, 14:00 PM -
Assessing the Completeness of Oncology Treatment Data from Administrative Claims: A Benchmarking Study Against Abstracted EHRs Using Patient-Level Linkages
Mar 10, 2025, 14:00 PM -
Assessing the Budget Impact and Time Savings of Introducing Nivolumab and Hyaluronidase SC to Patients Receiving Nivolumab IV Across Multiple Indications on a US Healthcare Plan
Mar 10, 2025, 14:00 PM -
Estimated Impact of Pre-Exposure Prophylaxis for COVID-19 on Quality of Life and Physical Distancing Among Immunocompromised Individuals and Caregivers
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization by Severity of Disease Among Adult Patients With Asthma in the United States
Mar 10, 2025, 14:00 PM -
Contemporary Treatment Patterns of Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Analysis of German Claims Data
Mar 10, 2025, 14:00 PM -
From Bias to Confidence: Exploring Quantitative Bias Analysis’ (QBA’s) Role in Matching Adjusted Indirect Treatment Comparison
Mar 10, 2025, 14:00 PM -
Administrative Incidence and Prevalence of Multiple Myeloma Using Administrative Claims Data From a Large Health Maintenance Organization in Colombia, 2015–2023
Mar 10, 2025, 14:00 PM
